Scienmag

SEPTEMBER 9, 2020

Massive price tag of COVID-19 response in 73 low- and middle-income countries underscores benefits of investing in pandemic preparedness New modelling research, published in The Lancet Global Health journal, estimates that it could cost low- and middle-income countries (LMICs) around US$52 billion (equivalent to US$8.60

Research 40

Research Development Medicine 40

Rethinking Clinical Trials

FEBRUARY 9, 2023

The trial was designed before the COVID-19 pandemic, but it was conducted during the height of the pandemic in New York. Because of rebalancing of physicians, there were more COVID-19 patients in the intervention group. -What is the explanation for the excess deaths at 30 days in the intervention group?

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

The Pharma Data

DECEMBER 3, 2020

The Phase 1 trial was a randomized, observer-blind, placebo-controlled study to assess the safety, reactogenicity and immunogenicity of the adjuvanted COVID-19 S-Trimer vaccine candidates formulated with different antigen levels. No serious adverse events related to the vaccine candidates studied were reported.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

NOVEMBER 15, 2020

Peng Liang , Founder and Chief Scientific Officer of Clover and inventor of the Trimer-Tag© technology, says, “A successful vaccine that can truly modulate the course of the COVID-19 pandemic must have four essential characteristics: safety, efficacy, scalability of manufacturing, and speed.

Vaccination 52

Vaccination Vaccine Manufacturing Life Science 52

The Pharma Data

JANUARY 31, 2021

Adjuvanted S-Trimer COVID-19 vaccine candidates demonstrated favorable safety and tolerability profiles and strong neutralizing immune responses in a phase 1 trial. The study found that Clover’s adjuvanted S-Trimer COVID-19 vaccine candidates were well tolerated and safe. CHENGDU, China , Feb.

Clinical Trials 52

Clinical Trials Clinical Trials Vaccination Vaccine 52

The Pharma Data

JANUARY 31, 2021

Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax’s CpG 1018 plus alum in the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. EMERYVILLE, Calif. and CHENGDU, China , Feb.

Vaccination 52

Vaccination Vaccine Trials Protein 52

XTalks

AUGUST 25, 2021

In-store food sampling is a key marketing tactic that virtually disappeared during the height of the COVID-19 pandemic. Much like all things pre-pandemic, food sampling took a hit throughout most of 2020 and into 2021. Related: Are Food Suppliers and Retailers Ready for the Post-Pandemic Future of Work?

Branding 98

Branding Marketing Nurses Production 98

Rethinking Clinical Trials

JULY 14, 2023

The study found that virtual parenting support coincided with the COVID-19 and helped families deal with the impact of the pandemic; GGC was delivered with high fidelity across cohorts, sessions, and sites; parents were satisfied with virtual GGC, with parents valuing the flexibility, connection and community.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

pharmaphorum

SEPTEMBER 15, 2020

Pharma’s go-to-market strategies have tended to be more traditional than those seen in non-regulated sectors, but there are some signs this is changing, with an acceleration in the pace of change forced by the COVID-19 pandemic that is allowing the industry to close its gap with faster, more nimble consumer brands.

Branding 120

Branding Marketing Pharma Companies Life Science 120

pharmaphorum

NOVEMBER 19, 2021

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic.

Sales 136

Sales Vaccination Vaccine Marketing 136

Rethinking Clinical Trials

JULY 6, 2023

During the COVID-19 pandemic, several regulatory authorities around the world introduced guidance on DCTs. There has been a growing sense of hesitancy about whether regulators will remain equally receptive to these decentralized methods when the pandemic recedes.

Trials 130

Trials Clinical Trials Clinical Trials Licensing 130

XTalks

NOVEMBER 27, 2021

The technical advisory group on SARS-CoV-2 virus evolution (TAG-VE) met on Friday to discuss B.1.1.529, The new variant was seen to be a cause of one of three major peaks in COVID-19 cases, one of the most recent of which is caused by the Delta variant. Related: FDA Authorizes Pfizer/BioNTech COVID-19 Vaccine for Kids 5 to 11.

Vaccination 97

Vaccination Vaccine Protein Scientist 97

The Pharma Data

MAY 5, 2021

Lilly hit by staff accusations, FDA scrutiny at COVID drug factories ( Reuters ). Covid cases through May due to variants before vaccinations drive a ‘sharp decline’ ( CNBC ). Younger people filling up COVID-19 intensive care wards in Americas, PAHO says ( Reuters ). In Focus: US.

Vaccination 52

Vaccination Vaccine Gene Therapy Contract Packaging 52

XTalks

NOVEMBER 10, 2020

Despite enhanced safety measures brought on by the COVID-19 pandemic, consumers are still skeptical about the safety, source and quality of the foods they buy, according to a new survey. Growing incidences of product adulteration, food fraud and foodborne illness outbreaks have created a need to re-evaluate supply chains.

Production 105

Production Sales Manufacturing Regulation 105

Pharmaceutical Technology

NOVEMBER 30, 2022

Furthermore, an increase in a sedentary lifestyle, partly brought on by the Covid-19 pandemic, saw a further rise in the obese population. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1%

Drugs 264

Drugs Manufacturing Hormones Contract Manufacturing 264

Rethinking Clinical Trials

NOVEMBER 9, 2022

The biggest inflection point for CardioNerds was COVID-era recruitment, when residents were asked to decide where to train for fellowship without having in-person visits. Like many trials during the COVID-19 pandemic, there were significant challenges and recruitment delays. pctGR, @Collaboratory1.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 30, 2023

There were also major changes to the clinic workflows during the COVID-19 pandemic and issues with data completeness with clinic turnover. There are new medications now that were not showing up that required regular updates to the dashboard. I am still optimistic that we will see some improvements in the outcomes we specified.

Trials 147

Trials Clinical Research Coordinator Medicine Clinical Trials 147

Pharmaceutical Technology

NOVEMBER 30, 2022

Furthermore, an increase in a sedentary lifestyle, partly brought on by the Covid-19 pandemic, saw a further rise in the obese population. The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. compared to a 5.1%

Drugs 246

Drugs Manufacturing Hormones Contract Manufacturing 246

Rethinking Clinical Trials

AUGUST 11, 2022

The platform trial model is not easy but not impossible; as we saw during the COVID-19 pandemic, it can be an effective way to discover important therapies and research in a fast and effective manner. Discussion Themes. Did the total cost include both coordinating center costs and site-level costs? Calling them out is step one.

Trials 130

Trials Clinical Trials Clinical Trials Research 130

Rethinking Clinical Trials

AUGUST 28, 2023

The work started before COVID-19, and the idea was to meet every six months. Training is also going to be essential to move this forward. – How did the pandemic impact the updates to the guidance? COVID-19 made us think about things differently, because one couldn’t apply rules, one had to apply principles.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

Rethinking Clinical Trials

AUGUST 28, 2023

The work started before COVID-19, and the idea was to meet every six months. Training is also going to be essential to move this forward. – How did the pandemic impact the updates to the guidance? COVID-19 made us think about things differently, because one couldn’t apply rules, one had to apply principles.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Development 130

pharmaphorum

OCTOBER 29, 2021

It is a key new product for Gilead as it faces pressure on its HIV franchise, which has been hit by reduced diagnoses and new therapy starts due to the COVID-19 pandemic, falling 8% to $4.2 COVID-19 therapy Veklury (remdesivir) continued to lead the charge at Gilead with a massive $1.9 billion for the full year.

Trials 52

Trials Sales FDA Approval Production 52

Rethinking Clinical Trials

JULY 19, 2023

Key study limitations were the need for remote delivery due to the COVID-19 pandemic and the lack of total representation of the broader U.S. Tags #pctGR, @Collaboratory1 The post Grand Rounds July 14, 2023: Lessons From the COORDINATE-Diabetes Trial (Christopher B. How do you incentivize patients to see this through?

Trials 130

Trials Cardiology Medicine Nurses 130

XTalks

APRIL 6, 2021

Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. For food supply chain experts, the onset of the COVID-19 pandemic can be viewed as a stress test to our global food system, highlighting its strengths and its weak points. The same went for meat and dairy.

Production 104

Production Sales Vaccination Vaccine 104

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products.

Production 104

Production Manufacturing Drugs Marketing 104

Rethinking Clinical Trials

MAY 5, 2023

The pilot trial was a pragmatic, unblinded, cluster-randomized, cluster-crossover trial that began in April 2018, paused from April 1-May 31, 2020 due to the COVID-19 pandemic, and concluded on Aug. Study sites were in the emergency department and medical intensive care unit at Vanderbilt University.

Trials 130

Trials Clinical Trials Clinical Trials Development 130

The Pharma Data

OCTOBER 19, 2020

Special edition cover of the classic song “We Are Family’ will be accompanied by a worldwide viral video starring celebrities, frontline health heroes, leaders and members of the public singing together in a show of solidarity and support for addressing present and future global public health needs, including COVID-19.

Scientist 52

Scientist Nurses Doctors Doctor 52

XTalks

MARCH 22, 2023

Pfizer is also the co-developer of what is arguably the most successful COVID-19 vaccine rollout. Top-Selling Drugs by Year It’s no surprise that the best-selling drug of 2022 was Pfizer/BioNTech’s COVID-19 vaccine, Comirnaty (COVID-19 vaccine, mRNA).

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

JULY 16, 2021

A growing trend toward plant-based eating and distrust in the safety of meat brought on by the COVID-19 pandemic has transformed plant-based meat into a popular alternative rather than a niche product enjoyed only by vegans and vegetarians. But yet, the price tag is still higher than real meat. Turning a Profit.

Protein 105

Protein Production Manufacturing Branding 105

pharmaphorum

JUNE 15, 2021

The adoption of New Science – a unique combination of the best in science and health technology that address significant unmet patient needs – is delivering more precise and effective treatments, but often at a higher price tag, according to new research. These will all help pay for New Science. . Success requires a future-fit enterprise .

Clinical Trials 89

Clinical Trials Clinical Trials Development Marketing 89

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. There is no easy answer to the question of how to incentivise innovation without restricting access.

Medicine 52

Medicine Marketing Manufacturing Production 52

pharmaphorum

AUGUST 28, 2020

But the advent of COVID-19 is proving to be something of a coming of age for digital epidemiology, which has been putting data from disparate sources to global use for the last 15 years. With COVID-19, it’s pretty commonplace to have that kind of data, but 10 years ago it wasn’t necessarily the case,” he said.

Medicine 64

Medicine Research 64

XTalks

DECEMBER 21, 2022

As the world continues to experience the effects and aftermath of the COVID-19 pandemic, lessons learned from the biggest global health crisis in recent times spurred changes and adaptations in the life sciences and healthcare. The pandemic necessitated a shift to off-site, remote and virtual clinical trial options.

Life Science 52

Life Science Gene Therapy Gene Clinical Trials 52

The Pharma Data

NOVEMBER 9, 2020

such as COVID-19. . The inspiration to release a special edition of the classic track initially came early this year as communities around the world were left reeling from the impact of COVID-19. . WeAreFamily #COVID19 #HealthforAll and tag @WHO, @The_WorldWeWant and @thewhof. supported by WHO.

Nurses 40

Nurses Doctors Doctor Scientist 40

Pharmaceutical Technology

MARCH 17, 2023

In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”. Watt explained that for newer, first-in-class drugs these types of agreements can also give healthcare systems safety in their decisions to approve certain drugs. Click here to watch this webinar and access the presentation.

Marketing 257

Marketing Drugs Research Analyst Manufacturing 257

pharmaphorum

DECEMBER 23, 2022

price tag of $475,000 when it was first launched in 2017 – and it becomes apparent that these may not be desirable treatment options for every patient and in every setting. Add to this the considerable cost of these medications – the first approved CAR-T, Novartis’ Kymriah (tisagenlecleucel), had a U.S.

Development 52

Development Drugs Clinical Development Antibody 52

pharmaphorum

FEBRUARY 26, 2021

COVID and beyond. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government. And at the tail end of 2020, a $6.5

Sales 124

Sales Production Pharma Companies Marketing 124